Samira Merali

16PUBLICATIONS
39CO-AUTHORS
Infant and child healthAdolescent healthCardiology (incl. cardiovascular diseases)PharmacogenomicsNgā rongoā me ngā whakamaimoa o te Māori (Māori medicine and treatments)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (16)

|Jun 24, 2025
Characterization of Apixaban Pharmacokinetics/Pharmacodynamics and Dose Assessment in Pediatric Patients with Congenital or Acquired Heart Disease.

Antoinette Ajavon-Hartmann, Praneeth Jarugula, Hyunmoon Back

|Apr 30, 2025
Modeling and Simulation to Inform Apixaban Dosing in Pediatrics With Acute Lymphoblastic Leukemia or Lymphoblastic Lymphoma Treated With Asparaginase.

Praneeth Jarugula, Toni Ajavon-Hartmann, Obinna Obianom

|Jan 28, 2025
Model-Informed Recommendation of Mavacamten Posology for Chinese Adults With Obstructive Hypertrophic Cardiomyopathy.

Xiaojie Wu, Shilpa Puli, Nanye Chen

|Sep 02, 2024
First-in-Human Study to Assess the Safety, Pharmacokinetics, and Pharmacodynamics of BMS-986308: A Renal Outer Medullary Potassium Channel Inhibitor.

Sharif I Soleman, Juan Maya, Paul Levesque

|Aug 29, 2024
Mavacamten for Obstructive Hypertrophic Cardiomyopathy: Rationale for Clinically Guided Dose Titration to Optimize Individual Response.

Anjali T Owens, Milind Desai, Matthew T Wheeler

|Aug 13, 2024
Characterization of mavacamten pharmacokinetics in patients with hypertrophic cardiomyopathy to inform dose titration.

Peter Chang, Vidya Perera, David H Salinger

Pageof 3

Frequent Collaborators

4 joint publications

Vidya Perera

3 joint publications

Amy J Sehnert

2 joint publications

Hyunmoon Back

2 joint publications

Elizabeth Ludwig